by Michelle Olufeso | Oct 5, 2024 | Life Sciences Focus
Introduction IAS 38 is a key International Financial Reporting Standard that governs the accounting for intangible assets. It outlines essential principles for recognising, measuring, and disclosing these assets, which can significantly impact financial statements. In...
by Michelle Olufeso | Oct 4, 2024 | Advanced Topics, Life Sciences Focus
Introduction IFRS 15 is a crucial standard for revenue recognition, particularly in the life sciences sector. This framework provides guidelines for identifying and recognising revenue from contracts with customers, ensuring consistency across industries. Licensing...
by Michelle Olufeso | Oct 3, 2024 | Life Sciences Focus
Financial statements might seem like a maze of numbers, but in life sciences, they tell the story of innovation, progress, and potential. For professionals in biotech and pharmaceutical companies, understanding these fundamental documents is crucial for making...
by Michelle Olufeso | Feb 5, 2023 | Life Sciences Focus
Red flags in life sciences financial statements are not always what they seem. What might signal distress in a traditional company could indicate progress in biotech. Conversely, seemingly positive indicators might mask underlying problems. Let’s unlock these...
by Michelle Olufeso | Jan 29, 2023 | Life Sciences Focus
In life sciences, cash is more than king – it is oxygen. Your company might have promising Phase II results and valuable intellectual property, but without careful cash flow management, even the most promising molecule won’t make it to market. The peculiarities...
